树突状细胞与慢性乙型肝炎*

doi:10.3969/j.issn.1672-5069.2011.05.034

摘要/Abstract

摘要： 树突状细胞（DC）是体内功能最强大的抗原提呈细胞，在HBV感染及CHB发病过程中起着重要的作用。近年来，DC已作为特异性免疫治疗手段被应用于CHB的治疗。

赖小欢,综述,潘兴南,审校. 树突状细胞与慢性乙型肝炎^*[J]. 实用肝脏病杂志, 2011, 14(5): 386-388.

[1] STEINMAN RM. Dendritic cells:Understanding immunogenicity[J]. Eur J Immunol，2007，37:S53-60.
[2] LIU YJ. Dendritic cells subsets and lineages and their functions in innateand adaptive immunity[J]. Cell，2001，106:259-262.
[3] AMSEN D，BLANDER JM，LEE GR，et al. Instruction of distinct CD4T helper cell fates by different notch ligands on antigen-presenting cells[J]. Cell，2004，117（4）:515-526.
[4] 龚非力. 医学免疫学[M]. 3版.北京:科学出版社，2009:111.
[5] THOMSON AW，DRAKES ML，ZAHORCHAK AF，et al. Hepatic dendritic cells:immunobiology and role in liver transplantation[J]. Leukoc Biol，1999，66:322-330.
[6] MIRIAN M，MARKUS G. Dendritic cell homeostasis[J]. Blood， 2009，113:3418-3427.
[7] O’CONNELL PJ，MPRELLI AE，LOGAR AJ，et al. Phenotypic and fuctionnal characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells[J]. Immunology，2000，165:795-803
[8] LIAN ZX，OKKADA T，HE XS，et al. Heterogeneity of dendritic cells in the mouse liver:identification and characterization of four distinct populations[J]. Immunology，2003，170:2323-2330.
[9] JOMANTAITE I，DIKOPOULOS N，KROGER A，et al. Hepatic dendritic cell subsets in the mouse[J]. Eer J Immunol，2004，34：355-365.
[10] PILLARISETTY VG，SHAH AB，MILLER G，et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition[J]. Immunology，2004，172:1009-1017.
[11] DUNN C，PEPPA D，KHANNA P，et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection[J]. Gastroenterology，2009，137:1289-1300.
[12] MORETTA L，FERLAZZO G，BOTTINO C，et al. Effector and regulatory events during natural killer-dendritic cell interactions[J]. Immunol Rev，2006，214:219-228.
[13] RUPRECHT CR，LANZAVECCHIA A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells[J]. Eur J Immunol，2006，36（4）:810-816.
[14] ZAMMIT DJ，LEFRANCOIS L. Dendritic cell-T cell interactions in the generation and maintenance of CD8 T cell memory[J]. Microbes Infect，2006，8（4）:1108-1115.
[15] GANEM D，PRINCE AM. Hepatitis B virus infection natural history and clinical consequences[J]. N Engl J Med，004，350（11）:1118-1129.
[16] ZHANG Z，CHEN D，YAO J，et al. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B[J]. Clin Immunol，2007，122（2）:173-180.
[17] OP DEN BROUW ML，BINDA RS，VAN ROOSMALEN MH，et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function:a possible immune escape mechanism of hepatitis B virus[J]. Immunology，2009，126（2）:280-289.
[18] ARIMA S，AKBAR SM，MICHITAKA K，et a1. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B:localization of HBV DNA and HBV RNA in blood DC by in situ hybridization[J]. Int J Mol Med，2003，11（2）:169-174.
[19] VANDER MOLEN RG，SPRENGERS D，BINDA RS，et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B[J]. Hepatology，2004，40（3）:738-746.
[20] OP DEN BROUW ML，BINDA RS，VAN ROOSMALEN MH，et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function:a possible immune escape mechanism of hepatitis B virus[J]. Immunology，2008，126:280-289.
[21] WOLTMAN AM，OP DEN BROUW ML，BIESTA PJ，et al. Hepatitis B virus lacks immune activating capacity，but actively inhibits plasmacytoid dendritic cell function[J]. PLoS ONE，2011，6（1）:e15324.doi:10.1371/journal.pone.0015324
[22] WANG FS，XING LH，LIU MX，et al. Dysfunction of peripheral blood den-dritic cells from patientswith chronic hepatitis B virus infections[J]. World J Gastroenterol，2001，7:537-541.
[23] ZHENG BJ，ZHOU J，QU D，et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection[J]. J Viral Hepat，2004，11（3）:217-224.
[24] TOSI D，VALENTI R，COVA A，et al. Role of cross talk between IFN-alpha induced monocyte-derived dendritic cells and NK cells in priming CD8 positive T cell responses against human tumor[J]. Immunology，2004，112:28-37.
[25] FONTENEAU JF，LARSSON M，BEIGNON AS，et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells[J]. J Virol，2004，78:5223-5232.
[26] LUFT T，LUETJENS P. IFN-αenhances CD40 ligand-mediated activation of immature monocyte derived dendritic cell[J]. Int Immunol，2002，14:367-380.
[27] 朱传武，钱峰，王海燕，等. 干扰素抗病毒应答与慢性乙型肝炎患者外周血树突状细胞功能的关系[J]. 抗感染病学，2004，1（2）:60-63.
[28] BONI C，PENNA A，OGG GS，et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B:New perspectives for immunotherapy[J]. Hepatology，2001，33:963-971.
[29] 李捍卫，朱慧芬，王福生，等. 慢性乙型肝炎患者抗病毒治疗前后外周血树突状细胞和淋巴细胞亚群的变化及意义[J]. 中华实验和临床病毒学杂志，2006，3（20）:43-46.
[30] COOKSLEY H，CHOKSHI S，MAAYAN Y，et al. Hepatitis B virus e-antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity[J]. Antimicrob Agents Chemother，2008，52（1）:312-320.
[31] 卢高峰，唐芙爱，郑鹏远，等. 恩替卡韦对慢性乙型肝炎患者树突状细胞功能的体外影响[J]. 世界华人消化杂志，2007，11:1292-1296.
[32] 朱传武，王海燕，钱峰，等. 干扰素A治疗对慢性乙型肝炎患者外周血树突状细胞抗原提呈作用的影响[J]. 中华医学杂志，2004，84（1）:14-17.
[33] AKBAR SM，FURUKAWA S，HASEBE A，et al. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer[J]. Int J Mol Med，2004，14（2）:295-299.
[34] DING CL，YAO K，ZHANG TT，et al. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells[J]. World J Gastroenterol，2003，9（7）:1512-1515.
[35] 李用国，陈敏，张大志，等. 自体树突状细胞疫苗治疗慢性乙型肝炎的临床研究[J]. 中华肝脏病杂志，2003，11（4）:206-208.
[36] AKABAR SM，ABE M，MASUMOTO T，et al. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers:vaccine-induced activation of antigen presenting dendritic cells[J]. J Hepatol，1999，30（5）:755-764.
[37] YOU Z，HUANG X，HESTER J，et al. Targeting dendritic cells to enhance DNA vaccine potency[J]. Cancer Res，2001，61（9）:3704-3711.
[38] GREDLER V，EBNER S，SCHANDA K，et al. Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells[J]. Clin Immunol，2010，134:296-304.
[39] STAEINMAN RM，BANCHEREAU J. Taking dendritictic cells into medicine[J]. nature，2007，449:419-426.

树突状细胞与慢性乙型肝炎^*

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	朱凌云, 张茂海, 崔莎莎, 张秋萍. 慢性乙型肝炎患者血清IL-12、IL-18水平和外周血单个核细胞FOXp3基因水平研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 816-819.
[5]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[6]	闵峰, 黄文琪, 吴卫兵, 张丽, 范荣华. 慢性乙型肝炎患者血清脂肪细胞因子水平变化及其临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 824-827.
[7]	张迎明, 申爽, 田飞, 孙园园. IFNL4和IL-28B基因多态性检测评估慢性乙型肝炎患者抗病毒治疗应答价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 828-831.
[8]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[9]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[10]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[11]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[12]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[13]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[14]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[15]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.